Novartis pharmaceuticals

Novartis is a global leader in the pharmaceutical industry, with a history rooted in the Swiss chemical and life sciences tradition. The company was formed in 1996 through the merger of Ciba-Geigy and Sandoz, two Swiss entities with deep historical ties to Basel. This merger created one of the largest healthcare companies in the world, focused on developing innovative medicines across various therapeutic areas including oncology, immunology, and neuroscience.

Manufacturing for Novartis is highly decentralized, utilizing a vast network of internal production sites and third-party contractors across Europe, North America, and Asia. While many of its high-tech biologics and specialized treatments are produced in Switzerland and the United States, the company maintains a global supply chain to serve more than 150 countries.

Today, Novartis AG functions as the ultimate parent company, headquartered in Basel, Switzerland. It is a publicly traded corporation listed on both the SIX Swiss Exchange and the New York Stock Exchange. The brand is synonymous with medical innovation and continues to operate as an independent global entity, following the successful spin-off of its eyecare division, Alcon, and its generic medicines unit, Sandoz, to focus strictly on integrated innovative medicines.